CC16 alleviates PM2.5-induced airway inflammation in asthmatic mice by targeting the E-cadherin-mediated ferroptosis regulatory axis Authors: Aili Wang, Shuo Yang, Fang Xu, Jianling Liu, Jinle Lin, Jian Wu Published: 2026 ABSTRACT AbstractAirway epithelial ferroptosis is critically involved in PM2.5-driven asthmatic airway damage, and our previous studies have demonstrated the protective role of club cell protein 16 (CC16) against fine particulate matter (PM2.5)-induced airway inflammation by inhibiting airway epithelial ferroptosis using C57BL/6 J mouse and TC-1 cell model. Nevertheless, it remains unclarified whether CC16 exerts its anti-ferroptotic effects through interacting with E-cadherin, which represents a core research gap absent in our previous studies. Herein, we established PM2.5-intervened asthmatic mice and TC-1 cell models to explore the undiscovered molecular mechanism. Quantitative proteomics combined with bioinformatics screening identified E-cadherin as a pivotal downstream target of CC16. PM2.5 exposure markedly inhibited E-cadherin expression and aggravated epithelial ferroptosis, while CC16 intervention efficiently restored E-cadherin levels, elevated NRF2/GPX4/SLC7A11 expression, suppressed ACSL4, and reduced lipid peroxidation. This study first verified the direct binding interaction between CC16 and E-cadherin via molecular docking, Co-IP and pull-down assays. Furthermore, CDH1 knockdown completely abolished CC16-mediated inhibition of ferroptosis and epithelial injury. Collectively, this work establishes a novel CC16/E-cadherin/ferroptosis signaling axis, demonstrating that E-cadherin is an indispensable mediator for CC16 to relieve PM2.5-triggered airway damage. These findings substantially complement and advance the mechanistic system of CC16-related airway protection, providing novel targets for environmental asthma therapy.Keywords: CC16, E-cadherin (CDH1), PM2.5, Asthma, Proteomics, Ferroptosis Introduction Fine particulate matter (PM2.5), a major component of air pollution, is a well-established exacerbating factor in asthma that contributes to airway inflammation, epithelial barrier dysfunction, and remodeling (Zhang et al., 2023a; Zhao et al., 2020; Cheng et al., 2024). PM2.5 exposure induces oxidative stress, which triggers iron overload and disrupts redox homeostasis, leading to ferroptosis in airway epithelial cells and acute lung injury (Wang et al., 2025a). Ferroptosis is an iron-dependent form of regulated cell death characterized by the accumulation of lipid peroxides (Dixon et al., 2012). Its core mechanism involves the dysregulation of cellular iron metabolism and the antioxidant defense system, primarily driven by the inhibition of the cystine/glutamate antiporter (SLC7A11/xCT) and glutathione peroxidase 4 (GPX4). This inhibition leads to depleted glutathione (GSH) levels, impaired reduction of lipid peroxides, and accumulation of reactive oxygen species (ROS) and malondialdehyde (MDA), a marker of lipid peroxidation (Mou et al., 2019; Dixon and Olzmann, 2024). The Nrf2 transcription factor is a central regulator of ferroptosis, transcriptionally activating genes involved in antioxidant response including SLC7A11 and heme oxygenase-1 (HO-1) genes (Yao et al., 2024). Acyl-CoA synthetase long-chain family member 4 (ACSL4) promotes ferroptosis by esterifying long-chain polyunsaturated fatty acids into membrane phospholipids, which are susceptible to peroxidation (Ding et al., 2023). Ferroptosis and acute damage compromise the integrity of the epithelial barrier, facilitating the penetration of allergens and pollutants into the submucosa and thereby initiating inflammatory cascades (Liu et al., 2024; Zhao et al., 2018). The adherens junction protein E-cadherin, encoded by the CDH1 gene, is fundamental to epithelial integrity (Lialios and Alimperti, 2025). Various insults, including environmental toxins and proteases, result in E-cadherin degradation, compromising the epithelial barrier. For instance, neutrophil extracellular traps and mast cell proteases have been shown to cleave E-cadherin, leading to increased permeability and inflammation (Ramu et al., 2021). Genetic variants in CDH1 and related cadherin family members have been linked to asthma (Ierodiakonou et al., 2011). Conditional deletion of E-cadherin in lung epithelial cells compromises barrier integrity and induces key asthmatic features, including goblet cell metaplasia, mucus hypersecretion, elevated CCL17, and eosinophil and dendritic cell infiltration, suggesting E-cadherin plays a central role in asthma pathogenesis (Post et al., 2018). Emerging evidence indicates that E-cadherin functionally interacts with ferroptosis across different disease contexts. In diffuse-type gastric cancer, loss-of-function mutations in CDH1 significantly increase cellular susceptibility to ferroptosis, suggesting its potential role as a biomarker for predicting ferroptosis sensitivity (Minikes et al., 2023). In respiratory pathologies such as lipopolysaccharide-induced acute lung injury and mixed granulocyte asthma, ferroptosis mediates the dysfunction of airway epithelial E-cadherin (Chen et al., 2024; Gan et al., 2024). These findings highlight a bidirectional regulatory relationship between E-cadherin integrity and ferroptotic activity in disease pathogenesis. Club cell secretory protein (CC16), also known as CC10, secretoglobin-1A1, club cell secretory protein (CCSP), uteroglobin or blastokinin, is predominantly secreted by airway non-ciliated epithelial cells and encoded by the SCGB1A1 gene (Broeckaert and Bernard, 2000). As documented in the Human Protein Atlas (HPA), CC16 acts as a potent endogenous phospholipase A2 inhibitor, which suppresses excessive lipid peroxidation and limits the production of pro-inflammatory lipid mediators. Reduced CC16 levels are closely associated with increased susceptibility to lung functional impairment and elevated asthma risk (Li et al., 2023; Zhai et al., 2019). Beyond its well-known anti-inflammatory activity, CC16 confers broad protection against environmental chemical lung injury (Han et al., 2023). Despite these established protective phenotypes, the precise molecular pathways by which CC16 mitigates PM2.5-mediated pulmonary toxicity remain incompletely characterized. Previous studies in conventional TC-1 cell and C57BL/6 J mouse models by our team revealed that CC16 alleviates PM2.5-induced asthma in mice by suppressing airway inflammation, mucus secretion, and airway resistance by inhibiting ferroptosis (Wang et al., 2025b). However, these prior works lacked targeted molecular screening of CC16-mediated lung protection against chemical toxicity. To address this gap, the present study adopts a discovery-driven strategy integrating public dataset mining and experimental validation. We systematically screened core candidate propein corresponding genes with the trends of increase-increase-decrease or decrease-decrease-increase among the Con, OVA, OVA+PM2.5 and OVA+PM2.5+CC16 groups. However, there was no co-expressed proteins that conform to the aforementioned trend were identified. Combined with the ferroptosis gene database, we further intersected and screened candidate proteins corresponding genes with the above trends. Ultimately, CDH1 was screened out as the core gene encoding E-cadherin presenting a decrease–decrease–increase expression pattern among the Con, OVA, OVA+PM2.5 and OVA+PM2.5+CC16 groups. Given that PM2.5 exposure was shown to induce oxidative stress and protease activity that led to E-cadherin downregulation (He et al., 2021; Zeng et al., 2024), We hypothesized that CC16 stabilizes E-cadherin expression, restrains epithelial ferroptosis, and thereby attenuates PM2.5-triggered lung injury and inflammation. This study aims to reveal a previously unrecognized CC16/E-cadherin/ferroptosis signaling cascade underlying environmental chemical-induced pulmonary damage, providing novel insights into the molecular basis of the anti-inflammatory action of CC16 and identify potential therapeutic strategies aimed at reinforcing the airway epithelial barrier in asthma. Materials and methods Mice were provided by Guangdong Scarstar Biotechnology Co., Ltd. (production certificate No. SCXK (Hunan) 2019–0004). All animal procedures were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of the South China University of Technology (Aprroval ID 2022101), and the study was conducted in compliance with the ARRIVE guidelines 2.0. Mice The C57BL/6 J strain was selected for its well-characterized immune response and extensive use in asthma and ferroptosis research. Adult male mice (6–8 weeks) were used to minimize hormonal variability associated with the female estrous cycle, consistent with standard practice in PM2.5 inhalation toxicology studies (Chen et al., 2023). Mice were maintained in a temperature-controlled room at 22 ± 2 °C and 50 ± 10% relative humidity on a 12 h light/dark cycle, with free access to standard laboratory chow (Ke'ao Xieli (Tianjin) Feed Co., Ltd., China) and sterilized drinking water (Animal Drinking Water Sterilizer equipment, BIST-WD-5500). Health status was monitored daily throughout the experimental protocol, including body weight, food and water intake, and general clinical observations. Mice were euthanized by cervical dislocation under anesthesia with pentobarbital sodium (50 mg/kg, i.p.). Experimental protocol The dosages of ovalbumin (OVA) (100 μg for sensitization, 2% aerosol for challenge), PM2.5 (2 mg/kg), and recombinant CC16 (2 mg/kg) were selected based on our previous study (Wang et al., 2025b), in which these doses effectively established the asthmatic phenotype and demonstrated CC16's protective effects without observable toxicity. Six-to-eight-week-old male C57BL/6 J mice (Guangdong Scarstar Biotechnology Co., Ltd., China) were randomly divided into four groups: Con, OVA, OVA+PM2.5, and OVA+PM2.5+CC16 (n = 6/group). Mice were sensitized with a mixture of 100 μg ovalbumin (OVA; A5503, Sigma-Aldrich, USA) and 8 mg aluminum hydroxide by intraperitoneal injection on days 0, 7, and 14. Mice were then challenged with 2% ovalbumin aerosol from days 21 to 27. Mice in the OVA+PM2.5 and OVA+PM2.5+CC16 groups were exposed to 2 mg/kg aerosolized high-pressure steam-sterilized PM2.5 for 2 h on days 28 and 29. CC16 (50291-M08H-2-mg, Sino Biological, China) was administered by nebulization on days 30 and 31 at a dosage of 2 mg/kg as previously described (Wang et al., 2025b). Twenty-four hours after the final challenge or PM2.5 exposure or CC16 intervention, lung tissues were obtained for proteomics analysis. (Note: The animals used in the present study were independently sampled and were not the same individuals used in our previous 2025 study (Wang et al., 2025b).) Coomassie blue staining Lung tissue was added to liquid nitrogen, and the sample was thoroughly ground under the conditions of −35 °C, 60 Hz, and 120 s, followed by centrifugation at 16260g for 10 min. The protein concentration of the supernatant was measured by a BCA kit (23,225, Thermo Fisher Scientific, USA) following the manufacturer's instructions. Equal amounts of protein (10 μg) were separated by 12% SDS-PAGE. The gel was stained with Coomassie Blue using the eStain LG protein staining kit (L00755C-500, GenScript, China) and imaged using an automatic digital gel image analysis system (Tanon1600, China). Protein digestion Using the measured protein concentrations, samples from different groups were diluted with lysis buffer to adjust concentrations and volumes to the same level. Next, 25 mM DTT (1,064,272, Adamas-beta, China) was added to the solution to a final concentration of 5 mM; the sample was then incubated at 55 °C for 30 min. Six times of the volume of pre-cooled acetone was added, and the sample was held at −20 °C for at least 4 h or overnight. After precipitation, the sample was centrifuged at 8000g for 10 min at 4 °C and then held at 2–3 min to evaporate the acetone. To redissolve the protein precipitate, 100 μL NH4HCO3 solution (50 mM) was added. Enzymolysis diluent was added on the basis of protein content (protein:enzyme = 50:1 (m/m), 100 μg of protein, 2 μg of enzyme). The solutions were incubated at 37 °C for 12 h or overnight. The enzymatic reaction was stopped by adjusting the pH to 3 with phosphoric acid. The samples were desalted on a SOLA™ SPE cartridge (60209–001, Thermo Fisher Scientific). After drying under a vacuum, samples were resuspended and iRT peptides (1:10) were added. LC-MS/MS analysis Proteomic data analysis was performed by Shanghai OE Biotech Co., Ltd. (Shanghai, China; No: DZLM2024031410). Nanoflow reversed-phase chromatography was performed on an U3000 ultra-high performance chromatography system (Thermo Fisher Scientific) that was coupled to a timsTOF Pro mass spectrometer (Bruker Corporation, MA, USA). Peptide (300 ng) was injected onto a 15 cm × 75 μm column (1.6 μm C18, IonOpticks). Mobile phases A and B were 0.1 vol% formic acid solution and 0.1 vol% CAN, respectively. The total run was 35 min (5% B 0–20 min, 22% B 20–24 min, 37% B 24–27 min, 80% B 27–30 min, 80% B 30–31 min, 2% B 31–35 min). For the timsTOF Pro settings, we used the instrument control software (Bruker timsControl v6) to define quadrupole isolation windows as a function of the TIMS scan time (diaPASEF). Capillary voltage was 1.4 kV, dry gas temperature was 180 °C, and dry gas flow rate was 3.0 L/min. The full MS scan range was set from 100 to 1700 m/z. The collision energy was ramped linearly as a function of the mobility from 59 eV at 1/K0 = 1.3 Vs/cm2 to 20 eV at 1/K0 = 0.7 Vs/cm2. Bioinformatics analysis Raw DIA data were processed using Spectronaut Pulsar 18.4 (Biognosys) (Shao-Yu et al., 2025), and the sequence database used for database searching was uniprot-Mus musculus-10,090-2024.2.1.fasta. Based on the original protein expression data, we calculated the mean expression level of each protein between comparison groups (n = 4) and obtained the fold change values. Proteins with |log₂(fold change)| > 1.2 and FDR < 0.05 were defined as significantly differentially expressed proteins (Supplementary data 1). Genes corresponding to differentially expressed proteins among CON, OVA, OVA+PM2.5 and OVA+PM2.5+CC16 groups were screened, KEGG pathway (http://www.genome.jp/kegg/) and enrichment analysis were performed. Genes corresponding to differentially expressed proteins with the trend of upregulation-upregulation-downregulation were selected as disease-promoting genes and intersected with ferroptosis-promoting genes (FerrDb database, http://www.zhounan.org/ferrdb/operations/download.html). Genes with the trend of downregulation-downregulation-upregulation were screened as disease-inhibiting genes and intersected with ferroptosis-suppressing genes to screen candidate ferroptosis-suppressing genes and perform enrichment analysis (Supplementary data 2). Cell culture and siRNA transfection The TC-1 cell line (iCell-m080, Cellverse Co., Ltd., China) is a mouse lung epithelial cell line immortalized by dual viral transformation with activated H-ras. TC-1 cells were used to model in vivo responses of bronchiolar and alveolar type II epithelial cells, which are directly exposed to inhaled PM2.5 in the airways and cells were cultured as previously described (Wang et al., 2025b; Wang et al., 2025c). Four experimental groups of TC-1 cells were established: PBS, PM2.5 alone, and CC16 (1 μg/mL) following exposure to PM2.5. For PM2.5 treatment, cells were exposed to 100 μg/mL PM2.5 and then incubated for 24 h. For siRNA transfection, TC-1 cells in the logarithmic growth phase were seeded in a 6-well plate at 3 × 105 cells per well and cultured at 5% CO2, 37 °C. Next, 200 μL of jetPRIME buffer (PT-114-75, Polyplus, France) was added to an Eppendorf tube, with siRNA to a final concentration of 15 nM and 4 μl jetPRIME reagent. The sample was vortexed and incubated at room temperature for 10 min. Next, 200 μl of the mixture was added to each plate. After 4–6 h, the medium was replaced with fresh culture medium, and cells were cultured for 48 h. The control, Cdh1, and NRF2 siRNAs were purchased from GenePharma Co. (Shanghai, China). Immunofluorescent staining Left lung tissues were fixed in 4% paraformaldehyde, and paraffin-embedded sections were prepared. The paraffin sections were subjected to gradient dewaxing treatment and antigen retrieval. Sections were incubated in 5% BSA for 30 min, followed by incubation with anti-E-cadherin (20874–1-AP, Proteintech, China) diluted at 1:500 with PBS at 4 °C overnight and subsequent incubation with red-fluorescent CoraLite594-conjugated goat anti-rabbit IgG (SA00013–4, Proteintech, China) in the dark at room temperature for 50 min after primary antibody was washed off. DAPI staining was performed for 10 min in the dark. Mounting medium containing anti-fluorescence quenching agent was used for mounting. Parallel positive and negative controls were prepared. E-cadherin-positive breast cancer tissues acted as the positive control to validate antibody performance. The negative control was generated by omitting the primary E-cadherin antibody, with sections incubated in antibody diluent and secondary antibody only. All samples underwent identical treatments. Observations and image acquisition were performed using a fluorescence microscope at 20× and 40× objectives. The ImageJ software was used to analyze the relative fluorescence signal densities in different groups. Western blot assays Protein samples were prepared as described above and separated by 10% SDS-PAGE. Samples were transferred onto PVDF membranes and blocked with 5% non-fat dry milk for 1 h at room temperature. The membrane was incubated with primary antibodies at 4 °C overnight: anti-E-cadherin (20874–1-AP, Proteintech, 1:1000), anti-NRF2 (A0674, Abclonal, China, 1:1000) and anti-GAPDH (60004–1-Ig, Proteintech, 1:5000). After washing three times with TBST, the blots were incubated with secondary antibody: peroxidase affinipure goat anti-rabbit IgG (111–035-003, Jackson, 1:10000). Protein expression was quantified using ImageJ software using pixel values normalized to GAPDH band intensity as an internal control. Quantitative real-time polymerase chain reaction (qRT-PCR) NameSequence (5′-3′)SizeMus GAPDHForwardTGTTTCCTCGTCCCGTAGA116 bpReverseGATGGCAACAATCTCCACTTTGMus NRF2ForwardTGCCCACATTCCCAAACAAG229 bpReverseCTGCCAAACTTGCTCCATGTMus ACSL4ForwardGGAAAGCAAACTGAAGGCGG199 bpReverseAATGGCCATGTCTGAAGGGGMus GPX-4ForwardTTCTCAGCCAAGGACATCGA169 bpReverseAGGCCAGGATTCGTAAACCAMus SLC7A11ForwardCCCAAGGGCATACTCCAGAA172 bpReverseCCAGCAAAGGACCAAAGACCMusCDH1ForwardReverseTGCATGAAGGCGGGAATCGTTGCATGAAGGCGGGAATCGT135 bp Measurement of MDA and GSH Levels of MDA (A003–1) and GSH (A006–2-1) in TC-1 cells were determined with assay kits from Nanjing Jiancheng Biological Co., Ltd., following the manufacturer's instructions. Iron and ROS assays The levels of iron and ROS in TC-1 cells were measured by an Iron Assay Kit (E-BC-F101, Elabscience, China) and ROS kit (E-BC-F005, Elabscience), following the manufacturer's instructions. Co-immunoprecipitation (Co-IP) assays Tissue samples were lysed in 500 μL of IP lysis buffer (87,788, Thermo Fisher Scientific), followed by centrifugation. Protein concentration was determined using BCA kits (P0010, Beyotime). We removed 100 μl from each sample as “input.” The E-cadherin antibody (20874–1-AP, Proteintech) was diluted in PBST to a final concentration of 10 μg/mL and added to 40 μl of Protein A/G magnetic beads (HY-K0202, MCE, USA). The mixture was incubated at room temperature for 30 min, followed by magnetic separation and collection of the magnetic beads. Cell lysate (containing 1 mg of protein) was added to homologous IgG (B900610, Proteintech) or antibody-conjugated Protein A/G magnetic beads, and the mixture was rotated at 4 °C overnight. Magnetic separation was performed to collect the magnetic beads. Samples were washed three times with PBST. Next, 1.5 x loading buffer was added and the sample was incubated for 5 min at 100 °C. The samples were subjected to western blot analysis using anti-CC16 (26909–1-AP, Proteintech) or E-cadherin antibodies. GST pull-down experiment Purified His-CDH1 and GST-CC16 proteins were synthesized by GENCEFE Biotech (Wuxi, China). First, 200 μL of Recombinant GST (Proteintech, AG25094) or GST-CC16 was mixed with His-CDH1; samples were retained as “input.” For pull-down experiments, 400 μL GST beads were aliquoted into two tubes and rinsed with 1 ml PBS; 10 μg of Recombinant GST or GST-CC16 were added, and the sample was rotated at 4 °C for 2 h. Beads were washed with PBS four times. His-CDH1 (10 μg) was added to the beads, and the samples were rotated at 4 °C overnight. Finally, the beads were washed and subjected to western blot analysis using anti-GST (66001–2-Ig, Proteintech) or anti-His (66005–1-Ig, Proteintech) antibodies. Statistical analysis In the vivo experiment, proteomics was conducted on 4 mice in each group, while other animal experiments were carried out on 6 mice in each group. All in vitro experiments (TC-1 cell assays) were performed with n = 6 independent biological replicates, not technical repeats. Data analysis was performed using GraphPad Prism 8.0 software (USA, San Diego, CA, USA). Data are presented as X ± S. For comparisons of means among multiple groups, one-way analysis of variance was used for statistical analysis; P ≤ 0.05 (two-sided) indicated statistical significance. If the differences were significant, further multiple comparisons between groups were conducted using the Tukey method. Results Identification of the target gene Cdh1 We previously found that CC16 alleviated the airway inflammation induced by PM2.5 in asthmatic mice and inhibited the ferroptosis of airway epithelial cells, suggesting CC16 may reduce airway inflammation by inhibiting ferroptosis of airway epithelial cells (Wang et al., 2025b). However, the specific mechanism had not been determined. We established a mouse model for asthma exposed to PM2.5 and analyzed four experimental groups: CON group, OVA group, OVA+PM2.5 group and OVA+PM2.5+CC16 group. Proteomics analysis of lung tissues from each group was conducted as described in the Methods. We first performed a temporal analysis of the expression patterns of genes corresponding to differentially expressed proteins (Fig. 1A–C), following the sequence CON–OVA–OVA+PM2.5–OVA+PM2.5+CC16, with the aim of screening for driver genes showing an “up–up–down” trend and suppressor genes showing a “down–down–up” trend across pairwise group comparisons. We intended to select key candidate genes and conduct enrichment analysis for the selected genes. However, no gene clusters conforming to these expression trends were identified. Identification of the target gene Cdh1. (A–C) Volcano plot of differentially expressed proteins between the experimental mouse groups: (A) OVA vs. CON. (B) OVA+PM2.5 vs. OVA. (C) and OVA+PM2.5+CC16 vs. OVA+PM2.5. (D) Venn diagram analysis of genes corresponding to differentially expressed proteins. Different colors represent different groups, the numbers in the figure indicate the number of intersections and the quantities of each group. (E) The intersection of driver genes with an expression trend of increasing (CON vs. OVA), increasing (OVA vs. OVA+PM2.5), and decreasing (OVA+PM2.5 vs. OVA+PM2.5+CC16). (F) The intersection of suppressor genes with an expression trend of decreasing (CON vs. OVA), decreasing (OVA vs. OVA+PM2.5), and increasing (OVA+PM2.5 vs. OVA+PM2.5+CC16). (G) Heatmap of the expression of suppressor genes with differential expression among the four experimental groups. (H–J) The box plot showing the differences in the expression of Cdh1 among the groups. Z indicates the CON group; X indicates the OVA group; XP indicates the OVA+PM2.5 group; and XPC indicates the OVA+PM2.5+CC16 group, n = 4 in each group. We thus focused on genes corresponding to differentially expressed proteins in the intergroup comparisons (OVA vs. CON, OVA+PM2.5 vs. OVA, OVA+PM2.5+CC16 vs. OVA+PM2.5) and used the FerrDb database (http://www.zhounan.org/ferrdb/operations/download.html) to select gene sets associated with ferroptosis. This database classifies ferroptosis-related genes into the following categories: drivers (promoting ferroptosis), suppressors (inhibiting ferroptosis), markers (indicating the occurrence of ferroptosis), and genes with unclear functions. We specifically screened for driver genes exhibiting an “up–up–down” expression trend, i.e., the intersection of genes identified as OVA vs CON up driver, OVA+PM2.5 vs OVA up driver, and OVA+PM2.5+CC16 vs OVA+PM2.5 down driver and suppressor genes exhibiting a “down–down–up” trend. Ultimately, one suppressor gene, Cdh1, conforming to the “down–down–up” expression trend was identified, as shown in Fig. 1D–F. Both the intergroup differential box plot and the heatmap of differentially expressed suppressor genes for the selected key candidate gene, Cdh1, demonstrated its characteristic expression trend (Fig. 1G–J). CC16 increased the expression of Cdh1 mRNA and E-cadherin protein in the lung tissues of mice with asthma induced by PM2.5 To validate the results above and investigate the role of Cdh1 in a PM2.5-induced murine asthma model, we examined the mRNA expression of Cdh1 and the expression of the encoded protein E-cadherin in lung tissues from the four groups using RT-PCR and western blot analysis. Compared with the CON group, the OVA group exhibited a significant decrease in both Cdh1 mRNA expression (p < 0.001) and E-cadherin protein levels (p < 0.001) (Fig. 2A–C). Furthermore, compared with the OVA group, the OVA+PM2.5 group showed a marked reduction in both Cdh1 mRNA and protein expression (p < 0.001). In contrast, administration of CC16 in the OVA+PM2.5+CC16 group significantly increased the expression levels of Cdh1 mRNA and E-cadherin protein compared with levels in the OVA+PM2.5 group (p < 0.001). These findings suggest that PM2.5 exposure suppresses the expression of Cdh1 and E-cadherin in PM2.5-induced asthmatic mice, while CC16 restores Cdh1 and E-cadherin expression. Expression of Cdh1 mRNA and E-cadherin protein in lung tissues of mice in each group. (A) Real-time quantitative PCR analysis of Cdh1 in lung tissues of mice treated as indicated. (B—C) Western blot analysis of E-cadherin in lung tissues of mice treated as indicated. (D). Immunofluorescence was used to detected the distribution of E-cadherin (red), and the nuclei were stained with DAPI (blue),the blue triangle indicate airway, the white arrows indicate E-cadherin positive airway epithelial cells. (E) The fluorescence intensity of each group was analyzed by Image J. CON indicates the control group; DAPI indicates 4′,6-diamidino-2-phenylindole. Data are presented as mean ± standard deviation and analyzed by one-way analysis of variance (n = 6), ***p < 0.001. Immunofluorescence staining also revealed a notable decrease in fluorescence intensity which reflects of E-cadherin protein expression in the airway epithelial cells of the OVA group compared with the CON group (Fig. 2D–E). E-cadherin expression was further reduced in the OVA+PM2.5 group compared with the OVA group. Notably, E-cadherin expression was significantly increased in the OVA+PM2.5+CC16 group compared with the OVA+PM2.5 group (p < 0.001), and arrows indicate typical positive staining cells. E-cadherin-positive breast cancer tissues were used as positive controls, which presented robust specific fluorescence and confirmed the effectiveness of the antibody. Meanwhile, no obvious specific signals were detected in the no-primary-antibody negative controls. These findings validated the high specificity of the present staining. CC16 directly interacts with E-cadherin We next examined the interaction between E-cadherin and CC16 using PLIP, with E-cadherin set as the reference chain. In the diagram in Fig. 3, CC16 is colored blue and E-cadherin pink. The binding free energy of the complex is −41.89 (kcal/mol) and the confidence score is 0.8715, and CC16 showed favorable embedding into the E-cadherin structural domain (Fig. 3A–B). Confirmation of CC16 and E-cadherin binding in vitro and in vivo. (A) Molecular docking analysis showed that CC16 binds to E-cadherin; ribbon and space-filling models of CC16 with E-cadherin are shown. (B) 3D binding models of CC16 with E-cadherin. (C) The 2D model showed the formation of massive hydrophobic bonds between CC16 and E-cadherin. (D) Co-IP results indicating the interaction between CC16 and E-cadherin. (E) GST pull-down assays using GST-CC16. Hydrogen bonds (indicated by solid blue lines in Fig. 3C) are formed between VAL-312 of CC16 and ASN-27 of E-cadherin; TYR-308 of CC16 and both TRP-2 and ILE-4 of E-cadherin; LEU-95 of E-cadherin and HIS-289 of CC16; GLN-52 of CC16 and both GLN-197 and ASN-168 of E-cadherin; and ASN-168 of E-cadherin and ARG-55 of CC16. In addition to these hydrogen bonds, several hydrophobic interactions (represented by gray dashed lines in the figure) were also identified. The results indicated a strong affinity between CC16 and E-cadherin protein. We further performed Co-IP assays to examine whether CC16 interacts with E-cadherin in lung tissue. Co-IP assays revealed an interaction between CC16 and E-cadherin in each group (Fig. 3D). We also performed in vitro GST pull-down assays using GST-CC16 and HIS-E-cadherin fusion proteins and confirmed that GST-CC16 directly interacts with HIS-E-cadherin (Fig. 3E). These data support the notion that CC16 binds directly to E-cadherin. CC16 suppression of ferroptosis in PM2.5-induced pulmonary epithelial cells involves E-cadherin For the four groups (CON, OVA, OVA+PM2.5, OVA+PM2.5+CC16), the functional enrichment analysis results were conducted for the genes corresponding to the differentially expressed proteins showing significant differences between the two groups. The KEGG enrichment analysis of the genes corresponding to the downregulated differentially expressed proteins in the OVA and CON groups, the genes corresponding to the down-regulated differentially expressed proteins in the OVA+PM2.5 and OVA groups, and the genes corresponding to the up-regulated differentially expressed proteins in the OVA+PM2.5+CC16 and OVA+PM2.5 groups mainly focused on metabolic pathways (Fig. 4A–C). CC16 suppression of ferroptosis in PM2.5-induced pulmonary epithelial cells involves E-cadherin. (A) The dot plot showing the enrichment score points for the top 15 entries corresponding to the downregulated differentially expressed proteins of the OVA and CON groups. (B) The dot plot showing the enrichment score points for the top 15 entries corresponding to the down-regulated differentially expressed proteins of the OVA+PM2.5 and OVA groups. (C) The dot plot showing the enrichment score points for the top 15 entries corresponding to the up-regulated differentially expressed proteins of the OVA+PM2.5+CC16 and OVA+PM2.5 groups (n = 4). (D–G) qRT-PCR was used to detect the mRNA expression levels of NRF2, GPX4, SLC7A11 and ACSL4. (H—K) Concentrations of iron, malondialdehyde (MDA), reactive oxygen species (ROS), and glutathione (GSH) were analyzed in each group of cells (n = 6). Data are expressed as mean ± standard deviation and were analyzed by one-way ANOVA. ns no significance, **p < 0.01, ***p < 0.001. From these results, we measured the mRNA expression levels of ferroptosis-related markers NRF2, GPX4, SLC7A11, and ACSL4, the level of iron, and levels of the lipid peroxidation markers MDA, ROS, and GSH in the experimental mouse pulmonary epithelial cell in vitro. The mRNA expressions of NRF2, GPX4, and SLC7A11 were decreased in the pulmonary epithelial cells of the PM2.5 group compared with the CON group (Fig. 4D–F, all p < 0.001), and ACSL4 was significantly increased (Fig. 4G, p < 0.001). The level of GSH in the pulmonary epithelial cell was significantly decreased, while iron, MDA, and ROS expression were significantly increased (Fig. 4H–K, p < 0.01). The mRNA expressions of NRF2, GPX4, and SLC7A11 of the CC16+PM2.5 group were significantly decreased compared with those in the PM2.5 group; ACSL4 expression was significantly increased, GSH expression was significantly decreased, and iron, MDA and ROS expression were significantly increased (Fig. 4D–K, all p < 0.05). All these changes were significantly reversed in the CC16+PM2.5+CDH1-siRNA group compared with the CC16+PM2.5+NC-siRNA group (all p < 0.01). No significant differences were observed in the expression of these ferroptosis markers between the CC16+PM2.5 group and the CC16+PM2.5+NC-siRNA group (p > 0.05). CC16 inhibition of inflammation in PM2.5-induced pulmonary epithelial cells involves E-cadherin We further investigated the protective effect of CC16 in PM2.5-treated mouse pulmonary epithelial cell model and using siRNA targeting Cdh1. The levels of inflammatory factors IL-5, IL-6, IL-13, IL-17 A, and IL-1β were significantly increased in the culture supernatant of mouse pulmonary epithelial cells of the PM2.5 group compared with the CON group (Fig. 5A–F, all p < 0.01). The levels of these inflammatory factors in the CC16+PM2.5 group were significantly decreased compared with levels in the PM2.5 group (all p < 0.01). Compared with levels in the CC16+PM2.5+NC-siRNA group, the levels of these inflammatory factors of the CC16+PM2.5+CDH1-siRNA group were significantly increased (all p < 0.001). No significant differences were observed in the expression levels of these inflammatory factors between the CC16+PM2.5 group and the CC16+PM2.5+NC-siRNA group (all p > 0.05). These results suggest that CC16 alleviation of airway inflammatory damage in mouse lung epithelial cells involves E-cadherin. CC16 inhibition of inflammation in PM2.5-induced pulmonary epithelial cells involves E-cadherin. (A) Q-PCR was used to detect the expression level of Cdh1 mRNA in each group of cells treated as indicated. (B—F) The expression levels of inflammatory factors IL-5, IL-6, IL-13, IL-17 A, and IL-1β in the cell culture supernatants of each group were determined by ELISA (n = 6). Data are expressed as mean ± standard deviation and were analyzed by one-way ANOVA. ns no significance, **p < 0.01, ***p < 0.001. CC16 regulates the expression of E-cadherin in lung epithelial cells induced by PM2.5 through the NRF2 pathway Studies have demonstrated that E-cadherin regulates ferroptosis (Bao et al., 2021; Li et al., 2024). Our previous research found that CC16 regulates ferroptosis in mouse lung epithelial cells through the NRF2 pathway (Wang et al., 2025b). Whether CC16 regulates the expression of E-cadherin through the NRF2 pathway to regulate ferroptosis in mouse lung epithelial cells induced by PM2.5 is unknown. To investigate the regulatory effect of CC16 on E-cadherin expression and its underlying mechanism, we investigated the effect of NRF2 on Cdh1 using NRF2 siRNA. We examined the following experimental groups in TC-1 cells: CON group, PM2.5 group, PM2.5+CC16 group, PM2.5+CC16+NC-siRNA group, and PM2.5+CC16+NRF2-siRNA group. We confirmed successful downregulation of NRF2 mRNA and protein with three siRNAs against NRF2 and selected NRF2-si-RNA2 for experiments (Fig. 6A–C). Compared with the CON group, the PM2.5 group showed a significant decrease in both Cdh1 mRNA and E-cadherin protein expression (p < 0.001) and the PM2.5+CC16 group exhibited a marked increase in the expression of both levels compared to PM2.5 group (p < 0.01) (Fig. 6D–F). Notably, both mRNA and protein levels were reduced in the PM2.5+CC16+NRF2-siRNA group compared with the PM2.5+CC16+NC-siRNA group (p < 0.05). No significant difference was observed between the PM2.5+CC16+NC-siRNA group and the PM2.5+CC16 group (p > 0.05). CC16 regulates PM2.5-induced E-cadherin expression in lung epithelial cells through the NRF2 pathway. (A–B) Western blot analysis of NRF2 to confirm the knockdown efficiency of NRF2 siRNAs. (C) Q-PCR result to confirm the knockdown efficiency of NRF2 siRNAs. (D–E) Western blot analysis of E-cadherin in cells of each group. (F) Q-PCR of Cdh1 mRNA in cells of each group (n = 6). Data are expressed as mean ± standard deviation, and one-way analysis of variance was used. ns no significance, *p < 0.05, **p < 0.01, ***p < 0.001. These findings suggest that PM2.5 exposure inhibits E-cadherin expression in lung epithelial cells and that CC16 regulates PM2.5-induced E-cadherin expression in lung epithelial cells via the NRF2 pathway. The mechanism may be associated with the role of CC16 in suppressing ferroptosis through the NRF2 pathway. Discussion Our previous studies found that CC16 alleviates PM2.5-induced airway inflammation and hyperresponsiveness in asthmatic mice by inhibiting ferroptosis in murine lung epithelial cells (Wang et al., 2025b) and reverses the PM2.5-induced suppression of cell viability in a concentration-dependent manner (Wang et al., 2025c). The studies have confirmed the protective effects of CC16 on PM2.5-induced ferroptosis and inflammation, and preliminarily revealed the regulatory correlation between CC16 and ferroptosis. However, no definite causal relationship between E-cadherin and ferroptosis was clarified in those works. In this current study, we further refined the molecular chain of this signaling pathway, and clearly validated that E-cadherin is a critical mediator driving ferroptosis occurrence. On this basis, we further verified that CC16 improves asthmatic airway injury through targeting the E-cadherin-dependent ferroptosis pathway, which greatly deepens the mechanistic understanding of the anti-inflammatory mechanism of CC16, and distinctly distinguishes this work from our previously reported serial literatures. This study, through proteomic analysis, identified Cdh1 encoding protein E-cadherin, which related to ferroptosis regulation (Zhang et al., 2023b), as playing a protective role in PM2.5-induced airway inflammation in asthmatic mice. This conclusion was further confirmed by qPCR, western blot, and immunofluorescence assays. E-cadherin expression was significantly reduced in the OVA+PM2.5 group compared with the OVA group and markedly increased in the OVA+PM2.5+CC16 group compared with the OVA+PM2.5 group. The Cdh1 gene encodes E-cadherin, a key member of the cadherin family that is primarily expressed in epithelial cells and is involved in intercellular adhesion and signaling. E-cadherin forms intercellular connections by binding via its extracellular domain to E-cadherin on adjacent cells, thereby maintaining epithelial barrier integrity. Decreased E-cadherin expression disrupts epithelial barrier function, increases the penetration of pathogens and harmful substances, and triggers inflammation and fibrosis (Türkeli et al., 2021; Tian et al., 2011). Loss of E-cadherin-mediated epithelial cell–cell contact promotes Th2-dependent inflammation and the development of asthma manifestations (Heijink et al., 2007; Young et al., 2025). E-cadherin/β-catenin protein complexes are actively involved in epithelial to mesenchymal transition, and downregulation of E-cadherin expression promotes β-catenin release and facilitates epithelial to mesenchymal transition (Auersperg et al., 1999; Chen et al., 2016). E-cadherin expression is regulated by multiple stimuli and signaling pathways. In a dextran sulfate sodium-induced ulcerative colitis mouse model and a TNF-α-induced Caco-2 cell monolayer intestinal barrier model, TNF-α-induced inflammatory and oxidative stress processes led to reduced E-cadherin expression (Wang et al., 2023). In lipopolysaccharide-induced acute lung injury in mice, E-cadherin dysfunction is induced in airway epithelial cells by ferroptosis (Chen et al., 2024). Furthermore, lipid peroxides generated during ferroptosis can directly damage E-cadherin, leading to loss of function, and ferroptosis may also disrupt E-cadherin expression by activating the ERK signaling pathway (Gan et al., 2024). Ferroptosis initiates neutrophil recruitment to airways, degrading extracellular matrix components through the release of elastase and activating matrix metalloproteinases to degrade membrane E-cadherin (Li et al., 2019; Ogawa et al., 2018). Our previous findings suggested that CC16 inhibits ferroptosis via the NRF2 pathway. In this study, experiments using NRF2 siRNA revealed significantly decreased levels of both Cdh1 mRNA and E-cadherin protein in the PM2.5+CC16 group, suggesting that CC16 may regulate ferroptosis via the NRF2 pathway, thereby modulating PM2.5-induced E-cadherin expression in lung epithelial cells. Research has found that decreased E-cadherin expression can further exacerbate ferroptosis (Bao et al., 2021), creating a vicious cycle that aggravates inflammatory injury. Studies indicated that E-cadherin, by maintaining intercellular junctions and signaling, suppresses the expression of ferroptosis-related genes via the E-cadherin/β-catenin/GPX4 axis (Li et al., 2024). E-cadherin mediates intercellular interactions that non-cell-autonomously suppress ferroptosis in epithelial cells, a process driven by its activation of the NF2 (merlin) and Hippo signaling pathway (Wu et al., 2019). Through molecular docking, we discovered that CC16 interacts with E-cadherin; this binding was further validated by pull-down and co-IP experiments. In vitro experiments using siRNA to knock down E-cadherin expression in murine lung epithelial cells revealed that, compared with the PM2.5+CC16 group, the PM2.5+CC16+E-cadherin-siRNA group exhibited significantly increased expression of the ferroptosis-related markers iron, MDA, and ACSL4 and decreased expression of GSH, GPX4, SLC7A11, and NRF2. These results suggest that CC16 inhibits ferroptosis in murine airway epithelial cells by interacting with E-cadherin, thus breaking the cycle where PM2.5-induced reduction of E-cadherin promotes ferroptosis and worsens inflammatory injury. These findings provide a novel molecular mechanism for the protective role of CC16 in PM2.5-associated lung injury and suggest that CC16 may be a potential therapeutic target for PM2.5-induced lung diseases such as chronic obstructive pulmonary disease and asthma. The results offer new insights for developing CC16-based therapeutic strategies targeting ferroptosis and E-cadherin for the prevention and treatment of PM2.5-related pulmonary diseases. This study has several limitations. Future experiments are required to elucidate the molecular mechanisms by which CC16 regulates ferroptosis, the Cdh1 gene, and E-cadherin. The protective effect of CC16 via NRF2 regulation has not been validated in animal models, and there is a lack of validation regarding correlative relationships using clinical specimens. In the proteomic analysis results, the differentially upregulated genes in the Cdh1-high vs. Cdh1-low comparison were primarily enriched in metabolic pathways; how Cdh1 regulates these downstream metabolic pathways requires further investigation. Additionally, the regulatory network of CC16 gene expression and its interactions with other cytokines, and their dynamic changes under different physiological and pathological conditions, are also worth exploration. This research will not only help expand understanding of the role of CC16 in inflammatory responses but may also reveal its potential application in therapeutic applications. In summary, our results suggest that CC16 alleviates PM2.5-induced airway inflammation by inhibiting ferroptosis in a mechanism dependent on E-cadherin. CC16 shows promise as a novel therapeutic target for counteracting PM2.5-aggravated asthma. These findings provide new targets for the treatment of asthma. Credit author statement I confirm that the corresponding author has made the following substantial contributions to the paper entitled “ CC16 alleviates PM2.5-induced airway inflammation in asthmatic mice by targeting the E-cadherin-mediated ferroptosis regulatory axis”: 1. Conceptualization & Design: Conceived the core idea, designed the overall research framework, and proposed the specific mechanism focusing on the regulation of CC16 on E-cadherin and ferroptosis. 2. Supervision & Management: Led the research project, supervised the experiments, and managed the data analysis process. 3. Revision: revised the manuscript for important intellectual content. 4. Resources & Funding: Acquired funding and provided essential research resources. All authors have read and approved the final manuscript and agree to be accountable for all aspects of the work. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Acknowledgments Acknowledgements We thank Gabrielle White Wolf, PhD, from Liwen Bianji (Edanz) (www.liwenbianji.cn) for editing the English text of a draft of this manuscript. Authors contributions Jian Wu and Jinle Lin designed, supervised and led out the experiments. Aili Wang and Shuo Yang conducted the experiments, data analysis and writing the primary manuscript. Fang Xu and Jianling Liu provided supervision and revised the manuscript. All the authors read and approved the final draft of the manuscript. Disclosure statements The authors have nothing to disclose. Funding This research was supported by the Hubei Provincial Natural Science Foundation (No. 2024AFB1032), the Guangdong Provincial Natural Science Foundation (No. 2023A1515011587) the Hubei Provincial Public Health Youth Top-notch Talent Training Program, the National Natural Science Foundation of China (No. 82302462), and the Guangdong Basic and Applied Basic Research Foundation (No. 2022A1515111206). Footnotes Supplementary data to this article can be found online at https://doi.org/10.1016/j.crtox.2026.100310. Contributor Information Jinle Lin, Email: lljjll2010@126.com. Jian Wu, Email: sywujian@scut.edu.cn. Supplementary data Supplementary material 1 Supplementary material 2 References Associated Data Supplementary Materials Supplementary material 1 Supplementary material 2